Interferon regulatory factors: Beyond the antiviral response and their link to the development of autoimmune pathology

Bayry, 2004, Dendritic cells and autoimmunity, Autoimmun Rev, 3, 183, 10.1016/S1568-9972(03)00104-6

Koutouzov, 2006, Type-I interferons and systemic lupus erythematosus, Autoimmun Rev, 5, 554, 10.1016/j.autrev.2006.05.002

Crispin, 2007, The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus, Autoimmun Rev, 6, 450, 10.1016/j.autrev.2007.01.014

Nehyba, 2009, Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family, Mol Biol Evol, 26, 2539, 10.1093/molbev/msp167

Takaoka, 2008, Interferon regulatory factor family of transcription factors and regulation of oncogenesis, Cancer Sci, 99, 467, 10.1111/j.1349-7006.2007.00720.x

Nehyba, 2002, A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein, Mol Cell Biol, 22, 3942, 10.1128/MCB.22.11.3942-3957.2002

Escalante, 1998, Structure of IRF-1 with bound DNA reveals determinants of interferon regulation, Nature, 391, 103, 10.1038/34224

Akira, 2006, Pathogen recognition and innate immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015

Tamura, 2008, The IRF family transcription factors in immunity and oncogenesis, Annu Rev Immunol, 26, 535, 10.1146/annurev.immunol.26.021607.090400

Waldner, 2009, The role of innate immune responses in autoimmune disease development, Autoimmun Rev, 8, 400, 10.1016/j.autrev.2008.12.019

Kimura, 1994, Involvement of the IRF-1 transcription factor in antiviral responses to interferons, Science, 264, 1921, 10.1126/science.8009222

Lin, 1998, Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation, Mol Cell Biol, 18, 2986, 10.1128/MCB.18.5.2986

Honma, 2005, Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS, Proc Natl Acad Sci U S A, 102, 16001, 10.1073/pnas.0504226102

Mittrucker, 1997, Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function, Science, 275, 540, 10.1126/science.275.5299.540

Klein, 2006, Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination, Nat Immunol, 7, 773, 10.1038/ni1357

Honda, 2005, IRF-7 is the master regulator of type-I interferon-dependent immune responses, Nature, 434, 772, 10.1038/nature03464

Takaoka, 2005, Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors, Nature, 434, 243, 10.1038/nature03308

Honda, 2004, Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells, Proc Natl Acad Sci U S A, 101, 2416, 10.1073/pnas.0307336101

Taki, 2005, IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells, J Immunol, 174, 6005, 10.4049/jimmunol.174.10.6005

Lee, 2007, Associations between interferon regulatory factor-1 polymorphisms and Behcet's disease, Hum Immunol, 68, 770, 10.1016/j.humimm.2007.06.002

Donn, 2001, Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group, Arthritis Rheum, 44, 802, 10.1002/1529-0131(200104)44:4<802::AID-ANR136>3.3.CO;2-7

Fife, 2007, No evidence for genetic association of interferon regulatory factor 1 in juvenile idiopathic arthritis, Arthritis Rheum, 56, 972, 10.1002/art.22425

Reilly, 2006, Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice, Eur J Immunol, 36, 1296, 10.1002/eji.200535245

Akahoshi, 2008, Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus, Lupus, 17, 568, 10.1177/0961203308089340

Sanchez, 2009, No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus, Lupus, 18, 230, 10.1177/0961203308096256

Harley, 2008, Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci, Nat Genet, 40, 204, 10.1038/ng.81

Salloum, 2010, Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients, Arthritis Rheum, 62, 553, 10.1002/art.27182

Eloranta, 2010, Type I interferon system activation and association with disease manifestations in systemic sclerosis, Ann Rheum Dis, 69, 1396, 10.1136/ard.2009.121400

Higgs, 2008, The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3, J Immunol, 181, 1780, 10.4049/jimmunol.181.3.1780

Higgs, 2010, Self protection from anti-viral responses—Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors, PLoS One, 5, e11776, 10.1371/journal.pone.0011776

Sigurdsson, 2005, Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus, Am J Hum Genet, 76, 528, 10.1086/428480

Graham, 2006, A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus, Nat Genet, 38, 550, 10.1038/ng1782

Reddy, 2007, Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans, Hum Genet, 121, 721, 10.1007/s00439-007-0367-6

Graham, 2007, Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus, Proc Natl Acad Sci U S A, 104, 6758, 10.1073/pnas.0701266104

Niewold, 2008, Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients, Arthritis Rheum, 58, 2481, 10.1002/art.23613

Qin, 2010, Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population, Nephrology (Carlton), 15, 710, 10.1111/j.1440-1797.2010.01327.x

Dieude, 2009, Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis, Arthritis Rheum, 60, 225, 10.1002/art.24183

Ito, 2009, Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population, Arthritis Rheum, 60, 1845, 10.1002/art.24600

Dieude, 2011, Immunogenetics of systemic sclerosis, Autoimmun Rev, 10, 282, 10.1016/j.autrev.2010.09.017

Miceli-Richard, 2007, Association of an IRF5 gene functional polymorphism with Sjogren's syndrome, Arthritis Rheum, 56, 3989, 10.1002/art.23142

Nordmark, 2009, Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome, Genes Immun, 10, 68, 10.1038/gene.2008.94

Bave, 2005, Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism, Arthritis Rheum, 52, 1185, 10.1002/art.20998

Higgs, 2011, Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway, Ann Rheum Dis, 10.1136/ard.2011.150326

Kimoto, 2011, Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome, J Rheumatol, 38, 310, 10.3899/jrheum.100486

Sigurdsson, 2008, Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5bp length polymorphism as strong risk factor for systemic lupus erythematosus, Hum Mol Genet, 17, 872, 10.1093/hmg/ddm359

Sanchez, 2010, Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus, Arthritis Rheum, 62, 3722, 10.1002/art.27753